Treatment with insulin detemir as add-on to liraglutide injection 1.8 mg + metformin resulted in statistically significant reductions in HbA1c and FPG compared to continued, unchanged treatment with liraglutide injection 1.8 mg + metformin alone (Table 6)
This leads to a scenario where new therapeutic strategies for diabetes must inevitably consider not only glycemic and weight control but also the reduction of both vascular and non-vascular complications
Your Klinic provider can help you determine which oral weight loss medication is the best fit based on your medical history, lifestyle, and insurance coverage
Leaner individuals may see slower but steady improvements in particularly resistant areas
Every prescription at Effecty requires an online consultation with a licensed provider, who will determine if treatment is appropriate for you
This ecosystem demonstrates how CGM innovation, personalization, and integration improve clinical care